[go: up one dir, main page]

EP2431475A3 - Bioabsorbierbares polymer mit 2-hydroxysäure-monomeren - Google Patents

Bioabsorbierbares polymer mit 2-hydroxysäure-monomeren Download PDF

Info

Publication number
EP2431475A3
EP2431475A3 EP20110193920 EP11193920A EP2431475A3 EP 2431475 A3 EP2431475 A3 EP 2431475A3 EP 20110193920 EP20110193920 EP 20110193920 EP 11193920 A EP11193920 A EP 11193920A EP 2431475 A3 EP2431475 A3 EP 2431475A3
Authority
EP
European Patent Office
Prior art keywords
pha
polyhydroxyalkanoate
glycolic acid
polymer
hydroxyacid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP20110193920
Other languages
English (en)
French (fr)
Other versions
EP2431475B1 (de
EP2431475A2 (de
Inventor
David P Martin
Frank A Skraly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tepha Inc
Original Assignee
Metabolix Inc
Tepha Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metabolix Inc, Tepha Inc filed Critical Metabolix Inc
Publication of EP2431475A2 publication Critical patent/EP2431475A2/de
Publication of EP2431475A3 publication Critical patent/EP2431475A3/de
Application granted granted Critical
Publication of EP2431475B1 publication Critical patent/EP2431475B1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/62Carboxylic acid esters
    • C12P7/625Polyesters of hydroxy carboxylic acids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/31504Composite [nonstructural laminate]
    • Y10T428/31507Of polycarbonate

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Prostheses (AREA)
  • Surgical Instruments (AREA)
EP11193920.3A 2002-05-10 2003-05-07 Bioabsorbierbares polymer mit 2-hydroxysäure-monomeren Expired - Lifetime EP2431475B1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37958302P 2002-05-10 2002-05-10
EP20030808364 EP1654373B1 (de) 2002-05-10 2003-05-07 Bioabsorbierbares polymer mit 2-hydroxysäure-monomeren
PCT/US2003/014573 WO2004038030A2 (en) 2002-05-10 2003-05-07 Bioabsorbable polymer containing 2-hdroxyacid monomers

Related Parent Applications (3)

Application Number Title Priority Date Filing Date
EP03808364.8 Division 2003-05-07
EP20030808364 Division EP1654373B1 (de) 2002-05-10 2003-05-07 Bioabsorbierbares polymer mit 2-hydroxysäure-monomeren
EP20030808364 Division-Into EP1654373B1 (de) 2002-05-10 2003-05-07 Bioabsorbierbares polymer mit 2-hydroxysäure-monomeren

Publications (3)

Publication Number Publication Date
EP2431475A2 EP2431475A2 (de) 2012-03-21
EP2431475A3 true EP2431475A3 (de) 2012-06-20
EP2431475B1 EP2431475B1 (de) 2019-07-10

Family

ID=32176356

Family Applications (2)

Application Number Title Priority Date Filing Date
EP11193920.3A Expired - Lifetime EP2431475B1 (de) 2002-05-10 2003-05-07 Bioabsorbierbares polymer mit 2-hydroxysäure-monomeren
EP20030808364 Expired - Lifetime EP1654373B1 (de) 2002-05-10 2003-05-07 Bioabsorbierbares polymer mit 2-hydroxysäure-monomeren

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP20030808364 Expired - Lifetime EP1654373B1 (de) 2002-05-10 2003-05-07 Bioabsorbierbares polymer mit 2-hydroxysäure-monomeren

Country Status (6)

Country Link
US (2) US8039237B2 (de)
EP (2) EP2431475B1 (de)
JP (2) JP4780961B2 (de)
AU (1) AU2003301617A1 (de)
ES (2) ES2741964T3 (de)
WO (1) WO2004038030A2 (de)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1105514B1 (de) 1998-08-04 2008-02-06 Metabolix, Inc. Herstellung von polyhydroxyalkanoaten aus polyolen
EP1163019B1 (de) 1999-03-25 2007-10-24 Metabolix, Inc. Medizinische vorrichtungen und verwendungen von polyhydroxyalkanoatpolymeren
EP1334181B1 (de) * 2000-11-17 2010-03-17 Metabolix, Inc. Herstellung von polyhydroxyalkanoaten mittlerer kettenlänge aus fettsäure-biosynthesewegen
ES2819189T3 (es) 2003-05-08 2021-04-15 Tepha Inc Tejidos y fibras médicos de polihidroxialcanoato
EP2221069B1 (de) 2004-08-03 2012-05-09 Tepha, Inc. Polyhydroxyalkanoate Nähte die sich nicht aufrollen
WO2006069282A2 (en) * 2004-12-22 2006-06-29 California Institute Of Technology Degradable p0lymers and methods of preparation thereof
US8016883B2 (en) * 2006-02-07 2011-09-13 Tepha, Inc. Methods and devices for rotator cuff repair
CA2640750C (en) * 2006-02-07 2013-12-17 Tepha, Inc. Polymeric, degradable drug-eluting stents and coatings comprising copolymers or homopolymers of 4-hydroxybutyrate
US9592325B2 (en) * 2006-02-07 2017-03-14 Tepha, Inc. Polymeric, degradable drug-eluting stents and coatings
US8979921B2 (en) * 2006-02-07 2015-03-17 Tepha, Inc. Polymeric, degradable drug-eluting stents and coatings
US9089627B2 (en) 2006-07-11 2015-07-28 Abbott Cardiovascular Systems Inc. Stent fabricated from polymer composite toughened by a dispersed phase
US7794495B2 (en) * 2006-07-17 2010-09-14 Advanced Cardiovascular Systems, Inc. Controlled degradation of stents
US7943683B2 (en) 2006-12-01 2011-05-17 Tepha, Inc. Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers
US20100210017A1 (en) * 2007-01-12 2010-08-19 Gill Ryan T Compositions and methods for enhancing tolerance for the production of organic chemicals produced by microorganisms
JP2010517638A (ja) * 2007-02-02 2010-05-27 トアニエ, インコーポレイテッド 腱および靱帯を修復するシステムおよび方法
US8048624B1 (en) 2007-12-04 2011-11-01 Opx Biotechnologies, Inc. Compositions and methods for 3-hydroxypropionate bio-production from biomass
EP2225373A4 (de) * 2007-12-13 2014-04-30 Glycos Biotechnologies Inc Mikrobielle umwandlung von ölen und fettsäuren in chemikalien von hohem wert
EP2231913B1 (de) * 2007-12-19 2013-01-23 Tepha, Inc. Medizinische vorrichtungen mit schmelzgeblasenen vliesstoffen aus poly-r-hydroxybutyrat und copolymeren
EP2313491A4 (de) * 2008-07-08 2011-12-07 Opx Biotechnologies Inc Verfahren, zusammensetzungen und systeme für die biosynthetische bioproduktion von 1,4-butandiol
WO2010003463A1 (en) * 2008-07-11 2010-01-14 Metabolic Explorer Method for polymerising glycolic acid with microorganisms
KR101085960B1 (ko) 2009-04-08 2011-11-22 주식회사 엘지화학 락테이트­글라이콜레이트 공중합체 또는 락테이트­글라이콜레이트­하이드록시알카노에이트 공중합체 생성능을 가지는 세포 또는 식물을 이용한 락테이트­글라이콜레이트 공중합체 또는 락테이트­글라이콜레이트­하이드록시알카노에이트 공중합체의 제조방법
AU2010298004B2 (en) 2009-09-27 2016-02-25 Opx Biotechnologies, Inc. Method for producing 3-hydroxypropionic acid and other products
US8809027B1 (en) 2009-09-27 2014-08-19 Opx Biotechnologies, Inc. Genetically modified organisms for increased microbial production of 3-hydroxypropionic acid involving an oxaloacetate alpha-decarboxylase
EP3639861B1 (de) 2010-03-26 2022-04-20 Tepha, Inc. Beschichtungen für die herstellung und anwendung von medizinischen polyhydroxyalkanoatvorrichtungen
CA2802212C (en) 2010-06-15 2015-03-24 Tepha, Inc. Medical devices containing dry spun non-wovens of poly-4-hydroxybutyrate and copolymers
US9511169B2 (en) 2010-06-15 2016-12-06 Tepha, Inc. Medical devices containing dry spun non-wovens of poly-4-hydroxybutyrate and copolymers with anisotropic properties
WO2012002572A1 (ja) * 2010-06-30 2012-01-05 日本水産株式会社 有用物質の製造方法
WO2012064526A1 (en) 2010-11-09 2012-05-18 Tepha, Inc. Drug eluting cochlear implants
WO2012075051A1 (en) 2010-11-29 2012-06-07 Micromidas, Inc. Pha-producing bacteria
US9370482B1 (en) 2011-09-09 2016-06-21 Harrison Yu Method of incorporating additives to shaped porous monocomponent biopolymer fibers during fiber orienting step
WO2013049161A1 (en) 2011-09-27 2013-04-04 Tepha, Inc. Controlled hydrolysis of poly-4-hydroxybutyrate and copolymers
CN103890186A (zh) * 2011-10-05 2014-06-25 宝洁公司 通过高丝氨酸生产丙烯酸酯和其它产品的微生物和方法
ES2546064T3 (es) 2011-11-22 2015-09-18 Heraeus Medical Gmbh Esterilización de monómeros polimerizables
ES2734126T3 (es) 2012-05-21 2019-12-04 Tepha Inc Composiciones biocerámicas reabsorbibles de poli-4-hidroxibutirato y copolímeros
MY185155A (en) 2012-05-31 2021-04-30 Micromidas Inc Polyhydroxyalkanoate derivatives, preparation and uses thereof
KR20150040359A (ko) 2012-08-10 2015-04-14 오피엑스 바이오테크놀로지스, 인크. 지방산 및 지방산 유도된 산물의 생산을 위한 미생물 및 방법
CN104797713A (zh) * 2012-11-27 2015-07-22 昭和电工株式会社 1,4-丁二醇的制造方法及微生物
ES2751398T3 (es) 2013-01-15 2020-03-31 Tepha Inc Implantes para regeneración de tejido blando y tejido duro
US10201640B2 (en) 2013-03-13 2019-02-12 Tepha, Inc. Ultrafine electrospun fibers of poly-4-hydroxybutyrate and copolymers thereof
US20150119601A1 (en) 2013-03-15 2015-04-30 Opx Biotechnologies, Inc. Monofunctional mcr + 3-hp dehydrogenase
CA2905602A1 (en) 2013-03-15 2014-09-18 Sarah M. Hoyt Flash evaporation for product purification and recovery
JP6603658B2 (ja) 2013-07-19 2019-11-06 カーギル インコーポレイテッド 脂肪酸及び脂肪酸誘導体の製造のための微生物及び方法
US11408013B2 (en) 2013-07-19 2022-08-09 Cargill, Incorporated Microorganisms and methods for the production of fatty acids and fatty acid derived products
US10689498B2 (en) 2013-08-20 2020-06-23 Tepha, Inc. Closed cell foams including poly-4-hydroxybutyrate and copolymers thereof
US9687585B2 (en) 2013-08-20 2017-06-27 Tepha, Inc. Thermoformed poly-4-hydroxybutyrate medical implants
US9302029B2 (en) 2013-10-31 2016-04-05 Tepha, Inc. Pultrusion of poly-4-hydroxybutyrate and copolymers thereof
WO2015069556A1 (en) 2013-11-05 2015-05-14 Tepha, Inc. Compositions and devices of poly-4-hydroxybutyrate
CA2933746C (en) 2013-12-26 2018-12-04 Tepha, Inc. Medical implants including laminates of poly-4-hydroxybutyrate and copolymers thereof
WO2015143000A1 (en) 2014-03-18 2015-09-24 Tepha, Inc. Micro-fiber webs of poly-4-hydroxybutyrate and copolymers thereof produced by centrifugal spinning
US10335257B2 (en) 2014-04-30 2019-07-02 Tepha, Inc. Three-dimensional resorbable implants for tissue reinforcement and hernia repair
ES2674807T3 (es) 2014-05-16 2018-07-04 Tepha, Inc. Dispositivos médicos que contienen materiales no tejidos hilados en seco de poli-4-hidroxibutirato y copolímeros con propiedades anisótropas
US10500303B2 (en) 2014-08-15 2019-12-10 Tepha, Inc. Self-retaining sutures of poly-4-hydroxybutyrate and copolymers thereof
ES2661648T3 (es) 2014-08-20 2018-04-02 Tepha, Inc. Implantes médicos de poli-4-hidroxibutirato termoformados
EP2993228B1 (de) 2014-09-02 2019-10-09 Cargill, Incorporated Herstellung von fettsäureestern
US10525172B2 (en) 2014-09-22 2020-01-07 Tepha, Inc. Oriented P4HB implants containing antimicrobial agents
CA2969429C (en) 2014-12-11 2020-10-27 Tepha, Inc. Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof
US10626521B2 (en) 2014-12-11 2020-04-21 Tepha, Inc. Methods of manufacturing mesh sutures from poly-4-hydroxybutyrate and copolymers thereof
AU2016222831B2 (en) 2015-02-27 2020-11-19 Championx Usa Inc. Compositions for enhanced oil recovery
WO2017196938A1 (en) 2016-05-13 2017-11-16 Ecolab USA, Inc. Corrosion inhibitor compositions and methods of using same
CA3029400A1 (en) 2016-06-28 2018-01-04 Ecolab Usa Inc. Composition, method and use for enhanced oil recovery
EP3577227A4 (de) 2017-02-02 2020-12-30 Cargill Inc. Genetisch veränderte zellen, die c6-c10-fettsäurederivate produzieren
ES2935295T3 (es) 2017-05-25 2023-03-03 Tepha Inc Formación continua de tubos de poli-4-hidroxibutirato y sus copolímeros
US11559604B2 (en) 2017-08-31 2023-01-24 University Of Westminster Nerve conduits
US10874498B2 (en) 2017-09-06 2020-12-29 Tepha, Inc. Calendered surgical meshes comprising polyhydroxyalkanoates
WO2019112925A1 (en) 2017-12-04 2019-06-13 Tepha, Inc. Vacuum membrane thermoformed poly-4-hydroxybutyrate medical implants
EP3802062B1 (de) 2018-06-11 2024-09-18 Tepha, Inc. Verfahren zum 3d-drucken von poly-4-hydroxybutyrat
EP3873546B1 (de) 2018-10-29 2023-07-12 Tepha, Inc. Verfahren zur herstellung von mesh-nahtmaterial aus poly-4-hydroxybutyrat und copolymere davon
KR102579087B1 (ko) * 2020-07-31 2023-09-15 킴벌리-클라크 월드와이드, 인크. 자동 생분해성 흡수 용품
JP2024510182A (ja) 2021-03-11 2024-03-06 テファ, インコーポレイテッド 乳房再建インプラント
WO2023049120A1 (en) 2021-09-21 2023-03-30 Sun Chemical Corporation Water-borne heat-sealable barrier coatings

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998051812A2 (en) * 1997-05-12 1998-11-19 Metabolix, Inc. Polyhydroxyalkanoates for in vivo applications
WO1999032536A1 (en) * 1997-12-22 1999-07-01 Metabolix, Inc. Polyhydroxyalkanoate compositions having controlled degradation rates
WO2000008198A1 (en) * 1998-08-04 2000-02-17 Metabolix, Inc. Polyhydroxyalkanoate production from polyols
WO2000056376A1 (en) * 1999-03-25 2000-09-28 Metabolix, Inc. Medical devices and applications of polyhydroxyalkanoate polymers
WO2002008428A2 (en) * 2000-07-21 2002-01-31 Metabolix, Inc. Production of polyhydroxyalkanoates from polyols

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3736646A (en) 1971-10-18 1973-06-05 American Cyanamid Co Method of attaching surgical needles to multifilament polyglycolic acid absorbable sutures
US3867190A (en) 1971-10-18 1975-02-18 American Cyanamid Co Reducing capillarity of polyglycolic acid sutures
EP0145233B2 (de) 1983-11-23 1991-11-06 Imperial Chemical Industries Plc Trennungsverfahrenfür ein 3-hydroxybutyrat-Polymer
US5245023A (en) 1987-06-29 1993-09-14 Massachusetts Institute Of Technology Method for producing novel polyester biopolymers
US5250430A (en) 1987-06-29 1993-10-05 Massachusetts Institute Of Technology Polyhydroxyalkanoate polymerase
US5229279A (en) 1987-06-29 1993-07-20 Massachusetts Institute Of Technology Method for producing novel polyester biopolymers
US5480794A (en) 1987-06-29 1996-01-02 Massachusetts Institute Of Technology And Metabolix, Inc. Overproduction and purification of soluble PHA synthase
ZA95627B (en) 1994-01-28 1995-10-05 Procter & Gamble Biodegradable copolymers and plastic articles comprising biodegradable copolymers
FR2719012B1 (fr) 1994-04-22 1996-07-12 Pomagalski Sa Pince débrayable d'un véhicule tracté par câble.
US5563239A (en) 1994-11-09 1996-10-08 Eastman Chemical Company Composition and process for the production of poly(3-hydroxyalkanoates)
US5819180A (en) 1996-07-31 1998-10-06 Ericsson Inc. Automatic call generator with a mobile telecommunications network based upon mobile subscriber's location
US6610764B1 (en) 1997-05-12 2003-08-26 Metabolix, Inc. Polyhydroxyalkanoate compositions having controlled degradation rates
DE69827948T2 (de) * 1997-07-25 2005-12-01 Metabolix, Inc., Cambridge Nukleierungsmittel für polyhydroxyalkanoate und andere thermoplastischen polyester, verfahren zu deren herstellung und ihre verwendung
EP1334181B1 (de) 2000-11-17 2010-03-17 Metabolix, Inc. Herstellung von polyhydroxyalkanoaten mittlerer kettenlänge aus fettsäure-biosynthesewegen

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998051812A2 (en) * 1997-05-12 1998-11-19 Metabolix, Inc. Polyhydroxyalkanoates for in vivo applications
WO1999032536A1 (en) * 1997-12-22 1999-07-01 Metabolix, Inc. Polyhydroxyalkanoate compositions having controlled degradation rates
WO2000008198A1 (en) * 1998-08-04 2000-02-17 Metabolix, Inc. Polyhydroxyalkanoate production from polyols
US6329183B1 (en) * 1998-08-04 2001-12-11 Metabolix, Inc. Polyhydroxyalkanoate production from polyols
WO2000056376A1 (en) * 1999-03-25 2000-09-28 Metabolix, Inc. Medical devices and applications of polyhydroxyalkanoate polymers
WO2002008428A2 (en) * 2000-07-21 2002-01-31 Metabolix, Inc. Production of polyhydroxyalkanoates from polyols

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KHELIFA N ET AL: "Synthesis of 2-hydroxy acid from 2-amino acid by Clostridium butyricum", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, ELSEVIER SCIENCE, GB, vol. 8, no. 23, 1 December 1998 (1998-12-01), pages 3429 - 3434, XP004143771, ISSN: 0960-894X *
STEINBUECHEL A ET AL: "DIVERSITY OF BACTERIAL POLYHYDROXYALKANOIC ACIDS", FEMS MICROBIOLOGY LETTERS, BLACKWELL PUBLISHING, AMSTERDAM, NL, vol. 128, no. 3, 15 May 1995 (1995-05-15), pages 219 - 228, XP000828495, ISSN: 0378-1097 *

Also Published As

Publication number Publication date
AU2003301617A8 (en) 2004-05-13
US8703449B2 (en) 2014-04-22
US20030211131A1 (en) 2003-11-13
JP2006501858A (ja) 2006-01-19
ES2741964T3 (es) 2020-02-12
EP1654373A4 (de) 2009-10-21
JP4780961B2 (ja) 2011-09-28
AU2003301617A1 (en) 2004-05-13
WO2004038030A2 (en) 2004-05-06
WO2004038030A3 (en) 2006-10-05
EP1654373A2 (de) 2006-05-10
US8039237B2 (en) 2011-10-18
US20120021471A1 (en) 2012-01-26
EP2431475B1 (de) 2019-07-10
JP4975782B2 (ja) 2012-07-11
EP2431475A2 (de) 2012-03-21
EP1654373B1 (de) 2012-08-15
JP2009261398A (ja) 2009-11-12
ES2395142T3 (es) 2013-02-08

Similar Documents

Publication Publication Date Title
EP2431475A3 (de) Bioabsorbierbares polymer mit 2-hydroxysäure-monomeren
Reshmy et al. Bacterial nanocellulose: engineering, production, and applications
EP1130042A3 (de) Polyhydroxyalkanoate die 3-Hydroxybenzoylalkancarbonsäure als Monomer enthalten, und Verfahren zu ihren Herstellung
WO2002012530A8 (en) 3-hydroxycarboxylic acid production and use in branched polymers
EP2338974A3 (de) Verstärkte Produktion von Lipiden enthaltend mehrfach ungesaettigte Fettsaeuren durch hochdichte Kulturen von eukaryotischen Mikroorganismen in Fermentoren
KR20110105845A (ko) 락트산 및 폴리락트산의 제조 방법
EP1411062A4 (de) Verfahren zur herstellung von dipeptid, dafür verwendete peptidsynthase und verfahren zur herstellung von peptidsynthase
EP1103523A3 (de) Aktivkohle und Verfahren zu ihrer Hertellung
AU6416086A (en) Reticulated cellulose product,sheets formed therefrom, methods and microorganisms for the production thereof
AU2002222586A1 (en) Process for producing lactide and process for producing polylactic acid from fermented lactic acid employed as starting material
NO20015422D0 (no) Fremgangsmåte for fremstilling av et fermenteringsmedium fra et fornybart råstoff
PL352499A1 (en) Compositions of prolonged active substance release, method of obtaining them and their applications
CN110849513B (zh) 一种可大规模生产的柔性生物质基压力传感器的制备工艺
AU2003240455A1 (en) Amorphous-crystalline block copolymers
EP1258470A3 (de) Verfahren zur Herstellung von optisch-aktiven Alkoholen
Ramachandran et al. Superlative short chain length and medium chain length polyhydroxyalkanoates microbial producers isolated from Malaysian environment
CA2355186A1 (en) Process for producing polymer
WO2005010164A3 (en) Nucleic acid biomaterials and methods of formation and use
EP0802258A3 (de) Verfahren zur Herstellung von Polydesoxyribonukleotiden, Verfahren zur Herstellung von chromosomalen DNS und Verfahren zur Herstellung von Chromosomen
AU7686000A (en) Process for producing ubiquinone-10
JP2005080529A (ja) 生分解性重合体の製造方法
DE69939876D1 (de) Methoden zur massenkultivierung von zellen die rekombinantes menschliches erythropoietin produzieren
WO2003033707A1 (fr) Gene d'enzyme participant a la synthese de polyester et procede de production de polyester a l'aide dudit gene
JPH01222788A (ja) ポリエステル共重合体の製造方法
DE50013563D1 (de) Verwendung von pankreatischer Procarboxypeptidase B zur Herstellung von Insulin

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AC Divisional application: reference to earlier application

Ref document number: 1654373

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

RIC1 Information provided on ipc code assigned before grant

Ipc: C12P 7/62 20060101AFI20120511BHEP

17P Request for examination filed

Effective date: 20121219

17Q First examination report despatched

Effective date: 20131213

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: TEPHA, INC.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: TEPHA, INC.

INTG Intention to grant announced

Effective date: 20180924

GRAJ Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20190124

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AC Divisional application: reference to earlier application

Ref document number: 1654373

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

Ref country code: AT

Ref legal event code: REF

Ref document number: 1153624

Country of ref document: AT

Kind code of ref document: T

Effective date: 20190715

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 60352136

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20190710

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1153624

Country of ref document: AT

Kind code of ref document: T

Effective date: 20190710

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191010

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191111

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190710

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190710

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190710

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190710

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2741964

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20200212

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191011

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190710

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190710

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190710

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190710

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190710

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190710

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 60352136

Country of ref document: DE

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20200603

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190710

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200531

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200531

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190710

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20200531

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200507

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200507

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200531

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20220323

Year of fee payment: 20

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190710

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20220308

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20220412

Year of fee payment: 20

Ref country code: ES

Payment date: 20220603

Year of fee payment: 20

Ref country code: DE

Payment date: 20220316

Year of fee payment: 20

REG Reference to a national code

Ref country code: DE

Ref legal event code: R071

Ref document number: 60352136

Country of ref document: DE

REG Reference to a national code

Ref country code: GB

Ref legal event code: PE20

Expiry date: 20230506

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20230630

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20230508

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20230506